NCT06991556
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06991556
Title An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | FRA | ESP | DEU | CZE | CAN | BRA | AUS

Facility Status City State Zip Country Details
University of California San Diego - Moores Cancer Center La Jolla California 92093-0658 United States Details
Saint Johns Cancer Institute Santa Monica California 90404 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Advanced Urology Ins Daytona Beach Daytona Beach Florida 32114 United States Details
Emory University School of Medicine-Winship Cancer Institute Atlanta Georgia 30322 United States Details
Associated Urological Specialists Chicago Ridge Illinois 60415 United States Details
Mass General Hospital Boston Massachusetts 02114 United States Details
Michigan Institute of Urology West Bloomfield Michigan 48322 United States Details
XCancer Omaha LLC Omaha Nebraska 68130 United States Details
Perlmutter Cancer Centre New York New York 10016 United States Details
Associated Med Professionals of NY Syracuse New York 13210 United States Details
Montefiore Medical Center The Bronx New York 10467 United States Details
MidLantic Urology Bala-Cynwyd Pennsylvania 19004 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Urology San Antonio San Antonio Texas 78229 United States Details
Inova Schar Cancer Institute Fairfax Virginia 22031 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Fred Hutch Cancer Research Seattle Washington 98109 United States Details
Novartis Investigative Site Adelaide South Australia 5000 Australia Details
Novartis Investigative Site Clayton Victoria 3168 Australia Details
Novartis Investigative Site Fortaleza Ceará 60140-025 Brazil Details
Novartis Investigative Site Porto Alegre Rio Grande do Sul 90610-000 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01221-020 Brazil Details
Novartis Investigative Site Vancouver British Columbia V5Z 1M9 Canada Details
Novartis Investigative Site Halifax Nova Scotia B3H 2Y9 Canada Details
Novartis Investigative Site Montreal Quebec H4A 3J1 Canada Details
Novartis Investigative Site Beijing Chaoyang 100021 China Details
Novartis Investigative Site Beijing 100034 China Details
Novartis Investigative Site Brno 656 53 Czechia Details
Novartis Investigative Site Olomouc 779 00 Czechia Details
Novartis Investigative Site Prague 150 06 Czechia Details
Novartis Investigative Site Nice Alpes Maritimes 06189 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Quint-Fonsegrives 31130 France Details
Novartis Investigative Site Suresnes 92150 France Details
Novartis Investigative Site Düsseldorf North Rhine-Westphalia 40225 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Lübeck 23538 Germany Details
Novartis Investigative Site Nürtingen 72622 Germany Details
Novartis Investigative Site Asti AT 14100 Italy Details
Novartis Investigative Site Padova PD 35128 Italy Details
Novartis Investigative Site Trento TN 38122 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Verona VR 37134 Italy Details
Novartis Investigative Site Zwolle Overijssel 8025 AB Netherlands Details
Novartis Investigative Site Dordrecht South Holland 3318 AT Netherlands Details
Novartis Investigative Site Hoofddorp 2134 TM Netherlands Details
Novartis Investigative Site Schiedam 3118 JH Netherlands Details
Novartis Investigative Site Kielce 25-640 Poland Details
Novartis Investigative Site Oświęcim 32-600 Poland Details
Novartis Investigative Site Skorzewo 60-185 Poland Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Singapore 308433 Singapore Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Seoul 06351 South Korea Details
Novartis Investigative Site Santander Cantabria 39008 Spain Details
Novartis Investigative Site Badajoz Extremadura 06080 Spain Details
Novartis Investigative Site Lugo Galicia 27003 Spain Details
Novartis Investigative Site Barcelona 08036 Spain Details
Novartis Investigative Site Córdoba 14004 Spain Details
Novartis Investigative Site Kaohsiung City 833 Taiwan Details
Novartis Investigative Site Tainan 704302 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field